Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Chipmakers turn cash into dividends--are we following what others

Chipmakers turn cash into dividends--are we following what others

posted on Mar 20, 2006 03:51AM
are doing? Maybe we will see a share buy-back program if that is the case. I am thinking that this week will bring some news--esp. about Intelasys since the debut is getting closer. Good luck to all, ads

http://yahoo.businessweek.com/investor/content/mar2006/pi20060317_078719.htm

Share
New Message
Please login to post a reply